235980 Stock Chart & Stats
₩2615.00
₩65.00(2.55%)
―
--
Day’s Range― - ―
52-Week Range₩2,235.00 - ₩8,650.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)118.83K
Market Cap
₩87.40B
Enterprise Value₩73.79K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.21
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-93.18
Shares Outstanding34,275,120
10 Day Avg. Volume132,986
30 Day Avg. Volume118,832
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
235980 FAQ
What was MedPacto, Inc.’s price range in the past 12 months?
MedPacto, Inc. lowest stock price was ₩2235.00 and its highest was ₩8650.00 in the past 12 months.
What is MedPacto, Inc.’s market cap?
MedPacto, Inc.’s market cap is ₩87.40B.
When is MedPacto, Inc.’s upcoming earnings report date?
MedPacto, Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 79 days.
How were MedPacto, Inc.’s earnings last quarter?
MedPacto, Inc. released its earnings results on Aug 13, 2026. The company reported -₩93.184 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is MedPacto, Inc. overvalued?
According to Wall Street analysts MedPacto, Inc.’s price is currently Undervalued.
Does MedPacto, Inc. pay dividends?
MedPacto, Inc. does not currently pay dividends.
What is MedPacto, Inc.’s EPS estimate?
MedPacto, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedPacto, Inc. have?
MedPacto, Inc. has 34,275,120 shares outstanding.
What happened to MedPacto, Inc.’s price movement after its last earnings report?
MedPacto, Inc. reported an EPS of -₩93.184 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.043%.
Which hedge fund is a major shareholder of MedPacto, Inc.?
Currently, no hedge funds are holding shares in KR:235980
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DongKoo Bio & Pharm Co. Ltd.
―
L&K BIOMED Co., Ltd.
―
CORESTEMCHEMON Inc.
―
Vaxcell-Bio Therapeutics
―
WITHUS PHARMACEUTICAL Co., Ltd.
―